Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial thiol- and metal-dependent enzymes represent a broad class of catalytic proteins essential for bacterial survival, pathogenesis, and antibiotic resistance. Thiol-dependent enzymes, such as sortases and various cysteine proteases, utilize a conserved cysteine residue for their catalytic mechanism, often involved in cell wall assembly or the processing of virulence factors (Mazmanian et al., 1999, Science). Metal-dependent enzymes, or metalloenzymes, utilize divalent cations like zinc or iron to catalyze essential reactions, including protein maturation by peptide deformylases and the hydrolysis of antibiotics by metallo-beta-lactamases (Bush & Bradford, 2016, Cold Spring Harb Perspect Med). These enzymes are critical targets for drug discovery because they are often essential for bacterial viability or contribute significantly to multi-drug resistance phenotypes (Giglione et al., 2000, EMBO J). Inhibitors of these enzymes typically function by chelating the essential metal cofactor or reacting with the active-site thiol group, thereby halting bacterial metabolism or restoring antibiotic sensitivity (Fast & Sutton, 2013, Biochim Biophys Acta). However, achieving selectivity over human orthologs, such as matrix metalloproteinases or human cysteine proteases, remains a primary challenge in the clinical development of these inhibitors (McGowan et al., 2010, Chem Biol).
Inhibition of enzymatic activity through metal ion chelation, covalent modification of active-site cysteine residues, or competitive binding to the active site.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial thiol- and metal-dependent enzymes.